Human Beta-defensin 1 in Vitiligo

Estimation of Tissue Level of Human Beta-defensin 1 (HBD-1) in Vitiligo Before and After Narrowband UVB Phototherapy: a Case-control Study

There is a need to know the role of human beta defensin-1 in vitiligo pathogenesis and the probability of finding newer and effective therapy for vitiligo in the future.

Inclusion Criteria:

• Patients with non-segmental vitiligo.
• Both genders.
• Age more than 18 years old.
• New cases or cases not receiving any treatment for at least 3 months prior to the study.

Exclusion Criteria:

• Universal or segmental vitiligo.
• Any contraindication to phototherapy treatment.
• History of autoimmune diseases or other systemic diseases.
• Any other skin disease.